Sakar Healthcare Limited (SAKAR) reports strong Q2 FY27 results with revenue growth of 53% and EBITDA growth of 114% YoY.
Dr. Reddy's Laboratories Ltd. (NSE: DRREDDY) announced DCGI approval for Zytorvi® in advanced esophageal squamous cell carcinoma.
Sun Pharmaceutical Industries Limited (SUNPHARMA) receives NCCN Category 2A designation for UNLOXCYT for locally advanced cutaneous squamous cell carcinoma.
Shilpa Medicare Limited (NSE: SHILPAMED) secures final approval for OERISTM, the world's first extended-release ondansetron injection, marking a significant.
Cipla Limited (NSE: CIPLA) partners with S BP Group for exclusive licensing of best-in-class HER2 bispecific ADC, aiming to enhance breast cancer treatment i.
AstraZeneca Pharma India Limited (ASTRAZEN) reports 30% revenue growth in Q1 FY2026-27, reaching INR 6,828 Mn, driven by strong portfolio and strategic partn.
Healthcare Global Enterprises Limited (HCG) reports Q1 FY27 results with 13% revenue growth, 20% Adjusted EBITDA, and improved margins.
Sakar Healthcare Limited (SAKAR) reports 38% YoY revenue growth in Q1FY27, with PAT rising 120%.
Glenmark Pharmaceuticals Limited (GLENMARK) advances its multi-country Phase 3 clinical trial for Trastuzumab rezetecan in platinum-resistant ovarian cancer.
Dr. Reddy's Laboratories Limited (DRREDDY) announces the first-to-market launch of Bosutinib Tablets 400mg in the U.S., expanding its oncology portfolio.